These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 9838361)
21. Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors. Mulloy LL; Wright F; Hall ML; Moore M Transplant Proc; 1999; 31(1-2):1210-3. PubMed ID: 10083541 [No Abstract] [Full Text] [Related]
22. Kidney transplantation at one center: 1-year results. Haberal M; Bilgin N; Karakayali H; Arslan G; Büyükpamukçu N; Velidedeoğlu E; Turan M; Akkoç H; Moray G; Tezel E Transplant Proc; 1996 Feb; 28(1):410-1. PubMed ID: 8644295 [No Abstract] [Full Text] [Related]
23. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression. Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909 [No Abstract] [Full Text] [Related]
24. Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression. Braun F; Canelo R; Lorf T; Schütz E; Grupp C; Müller GA; Ringe B Transplant Proc; 2000 Feb; 32(1):115-6. PubMed ID: 10700989 [No Abstract] [Full Text] [Related]
25. Renal transplant recipients with graft survival longer than 20 years: report on 107 cases. Kyllönen L; Koskimies S; Salmela K Transplant Proc; 2001 Jun; 33(4):2444-5. PubMed ID: 11406203 [No Abstract] [Full Text] [Related]
26. Mycophenolate mofetil in renal graft recipients with increased immune risk of graft loss. Boratyńska M; Magott M; Klinger M; Smolska D; Rychlewska B; Myszka K; Szepietowski T; Szyber P; Patrzalek D Transplant Proc; 2002 Mar; 34(2):553-5. PubMed ID: 12009621 [No Abstract] [Full Text] [Related]
27. Does recipient age affect the outcome of renal transplantation? Samhan M; Al-Mousawi M; Al-Muzairai I; Nair P; Fathi T; Johny KV Transplant Proc; 2001 Aug; 33(5):2699-700. PubMed ID: 11498129 [No Abstract] [Full Text] [Related]
28. Factors affecting the graft survival in cadaver donor kidney transplantation. Chon SE; Lee KW; Joh JW; Kim SJ; Park JH; Lee SK; Oh HY; Huh WS; Kim YI; Lee BB Transplant Proc; 2003 Feb; 35(1):147-8. PubMed ID: 12591342 [No Abstract] [Full Text] [Related]
29. Effect of donor age on outcome of living related kidney transplantation. Kim YL; Kim JH; Kwon TH; Cho DK; Kim YW; Chang SI; Chung SK; Chang SK Transplant Proc; 1996 Jun; 28(3):1580-1. PubMed ID: 8658793 [No Abstract] [Full Text] [Related]
30. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center. Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642 [No Abstract] [Full Text] [Related]
31. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor. Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498 [No Abstract] [Full Text] [Related]